Why Invest in Fortis Medical Devices?

Pioneering Technology

  • Innovative Solution: cueStim utilizes advanced synchronized electrical stimulation and intelligent sensing technology to deliver personalized therapy.

  • Clinical Validation: Demonstrated significant reductions in FoG episodes in clinical studies, with over 70% reduction in time in FoG.

Market Opportunity

  • Growing Need: Parkinson's disease affects over 10 million people globally, with FoG impacting nearly 50% of persons with Parkinson's disease.

  • Untapped Potential: Limited effective treatments currently exist for FoG, presenting a substantial market opportunity for cueStim.

Regulatory Milestones

  • FDA Breakthrough Device Designation: Recognized for its potential to provide a more effective treatment for an irreversibly debilitating condition.

  • Active Engagement with FDA: Participation in the FDA's Total Product Life Cycle Advisory Program (TAP) to expedite development and review processes.

Strong Leadership and Expertise

  • Experienced Team: Comprised of industry experts, leading researchers, and seasoned executives with a proven track record in medical device development.

  • Strategic Partnerships: Collaborations with renowned institutions and manufacturing partners to ensure quality and scalability.

Stay Informed and Connect with Us

We invite you to be a part of our mission to revolutionize Parkinson's care. Your investment can help bring cueStim to market, making a tangible difference in the lives of those affected by Parkinson's disease.

Express Your Interest

To learn more about investment opportunities with Fortis Medical Devices and to receive updates on our progress, please fill out the form below. Our team will reach out to you with additional information and answer any questions you may have.

Contact Form